Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial (2004)
- Authors:
- Autor USP: MIGLIARI, DANTE ANTONIO - FO
- Unidade: FO
- Subjects: XEROSTOMIA; SALIVA ARTIFICIAL; SÍNDROME DE SJOGREN
- Language: Inglês
- Abstract: OBJECTIVE: To evaluate the efficacy of oral moisturizing gel (Oral Balance) in xerostomic patients with primary Sjogren's syndrome (SS). METHOD AND MATERIALS: Twenty-one xerostomic patients with primary SS were subjected to a single-blind trial in which the efficacy of Oral Balance gel in reducing xerostomia and xerostomia-related oral symptoms was compared with that of a placebo. Both gels were packaged identically and were indiscernible in appearance and taste. Xerostomia was confirmed for all the patients through measurement of stimulated whole saliva. Patients began using the Oral Balance gel three times a day for 90 days, and were then switched to a gel placebo to be used in the same way for the same length of time. Clinical response was evaluated through the patients' subjective assessment (improved, worsened, or unaltered) of both gels. RESULTS: Neither the Oral Balance gel nor the gel placebo affected the salivary output of the patients. The Oral Balance gel presented a substantial statistically significant advantage in the control of burning mouth, mastication, and swallowing. No statistically significant relief of the isolated sensation of oral dryness was established. CONCLUSION: Oral Balance is a useful tool in the management of dryness-related oral symptoms in primary SS, but there is room for enhancing the overall properties of topical preparations designed to reduce oral complaints in xerostomic patients
- Imprenta:
- Publisher place: Carol Stream
- Date published: 2004
- Source:
- Título: Quintessence International
- ISSN: 0033-6572
- Volume/Número/Paginação/Ano: v. 35, n. 5, p.392-396, May 2004
-
ABNT
ALVES, Marilene B. et al. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence International, v. 35, n. 5, p. 392-396, 2004Tradução . . Acesso em: 29 dez. 2025. -
APA
Alves, M. B., Motta, A. C. F., Messina, W. C., & Migliari, D. A. (2004). Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence International, 35( 5), 392-396. -
NLM
Alves MB, Motta ACF, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence International. 2004 ; 35( 5): 392-396.[citado 2025 dez. 29 ] -
Vancouver
Alves MB, Motta ACF, Messina WC, Migliari DA. Saliva substitute in xerostomic patients with primary Sjogren's syndrome: a single-blind trial. Quintessence International. 2004 ; 35( 5): 392-396.[citado 2025 dez. 29 ] - Niveis da iga secretoria na saliva total nao-estimulada, de individuos fumantes e nao-fumantes por imunodifusao radial simples
- Estudo in vitro da pelicula adquirida do esmalte derivada da saliva total
- Carcinoma verrugoso em cisto odontogenico
- Líquen plano oral: relação clínico-histopatológica, imunofluorescência direta, associação com medicação sistêmica e terapêutica
- Efetividade do azul de toluidina na identificação de áreas displásicas na quelite actínica e no líquen plano oral
- Efeitos de medicação sistêmica nos sintomas e nas formas clínicas do líquen plano oral
- Oral status and Candida colonization in patients with Sjögren’s Syndrome
- Utilização do laser de baixa potência na prevenção e tratamento da mucosite oral em pacientes pediátricos
- Leucoplasia com atipia intensa tratamento com laser com CO2 e diodo
- Refractory Pigmentation Associated with Laugier-Hunziker Syndrome following Er:YAG Laser Treatment
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
